Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
(TSX:
BLCO
)
21.26
UNCHANGED
Streaming Delayed Price
Updated: 3:50 PM EST, Nov 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about BLCO
< Previous
1
2
3
4
Next >
Bausch + Lomb Releases Annual Environmental, Social and Governance Report
May 01, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces the Presentation of New Scientific Data on Products and Pipeline Programs at the American Society of Cataract and Refractive Surgery Annual Meeting
April 26, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces 2023 Annual Meeting of Shareholder Results
April 25, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces U.S. Launch of StableVisc™ Cohesive Ophthalmic Viscosurgical Device and TotalVisc™ Viscoelastic System
April 24, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces the Presentation of New Data on Products and Pipeline Programs at the Association for Research in Vision and Ophthalmology Meeting
April 20, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Reports More Than 65 Million Units of Contact Lens, Eye Care and Lens Care Materials Recycled Through ONE by ONE and Biotrue® Eye Care Recycling Programs
April 18, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Will Release First-Quarter 2023 Financial Results on May 3
April 17, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb and Heidelberg Engineering Announce the Introduction of SeeLuma™ Fully Digital Surgical Visualization Platform
April 13, 2023
From
Bausch + Lomb
Via
Business Wire
Bausch + Lomb Appoints Bob Bailey as Executive Vice President and Chief Legal Officer and Andrew Stewart as President, Ophthalmic Pharmaceuticals
April 12, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb and Novaliq Announce Publication of Second Pivotal Phase 3 Data on NOV03 (Perfluorohexyloctane) in American Journal of Ophthalmology
March 22, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces Fourth-Quarter and Full-Year 2022 Results
February 22, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Appoints Brent Saunders as Chief Executive Officer and Chair of the Board of Directors, Effective March 6, 2023
February 15, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
New Bausch + Lomb Social Media Campaign Highlights What ‘Sights’ Inspire AMD Patients
February 07, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb and Modulight Announce FDA Approval of ML6710i Photodynamic Laser for Use with Bausch + Lomb’s VISUDYNE® (Verteporfin for Injection)
February 01, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2022 Financial Results on February 22
January 23, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Acquires AcuFocus, Inc.
January 17, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Introduces Enhanced PreserVision® AREDS 2 Formula Mini Soft Gels with OCUSorb™
January 09, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Publishes Update Presentation for the 41st Annual J.P. Morgan Healthcare Conference
January 09, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces Participation at the 41st Annual J.P. Morgan Healthcare Conference
January 05, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb and Novaliq Announce Publication of Pivotal Phase 3 Data on NOV03 (Perfluorohexyloctane) in Ophthalmology
January 04, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb and Glaucoma Research Foundation Announce Launch of Screen, Protect, Cure Campaign In Recognition of Glaucoma Awareness Month
January 03, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today